{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:57:16Z","timestamp":1785542236172,"version":"3.56.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2,15]]},"DOI":"10.1097\/tp.0b013e318276a237","type":"journal-article","created":{"date-parts":[[2012,12,5]],"date-time":"2012-12-05T21:15:04Z","timestamp":1354742104000},"page":"470-478","source":"Crossref","is-referenced-by-count":72,"title":["Epidemiology of Posttransplantation Lymphoproliferative Disorder in Adult Renal Transplant Recipients"],"prefix":"10.1097","volume":"95","author":[{"given":"Muir","family":"Morton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Coupes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Klapper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Byers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"Vallely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Picton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210129","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1523-1755.2004.00741.x","article-title":". Risk of malignancy with long-term immunosuppression in renal transplant recipients.","volume":"66","author":"Agraharkar","year":"2004","journal-title":"Kidney Int"},{"key":"R2-10-20210129","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report.","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"R3-10-20210129","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1111\/j.1600-6143.2006.01540.x","article-title":". Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French registry.","volume":"6","author":"Caillard","year":"2006","journal-title":"Am J Transplant"},{"key":"R4-10-20210129","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.TP.0000165098.49658.F3","article-title":"Lymphoproliferative disease after renal transplantation in Australia and New Zealand.","volume":"80","author":"Faull","year":"2005","journal-title":"Transplantation"},{"key":"R5-10-20210129","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1046\/j.0007-1323.2001.01924.x","article-title":". Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients.","volume":"88","author":"Libertiny","year":"2001","journal-title":"Br J Surg"},{"key":"R6-10-20210129","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1111\/j.1600-6143.2011.03704.x","article-title":". Time trends in risk and risk determinants of non-Hodgkin lymphoma in solid organ transplant recipients.","volume":"11","author":"Fernberg","year":"2011","journal-title":"Am J Transplant"},{"key":"R7-10-20210129","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1097\/01.tp.0000290232.65830.e7","article-title":". A quantitative assay for Epstein-Barr virus-specific immunity shows interferon-gamma producing CD8 T cells increase during immunosuppression reduction to treat posttransplant lymphoproliferative disease.","volume":"84","author":"Guppy","year":"2007","journal-title":"Transplantation"},{"key":"R8-10-20210129","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.trim.2005.02.001","article-title":". EBV-specific memory CD8 T cell phenotype and function in stable solid organ transplant patients.","volume":"14","author":"Macedo","year":"2005","journal-title":"Transpl Immunol"},{"key":"R9-10-20210129","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/00007890-200205270-00014","article-title":". Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease.","volume":"73","author":"Smets","year":"2002","journal-title":"Transplantation"},{"key":"R10-10-20210129","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.autrev.2007.02.012","article-title":"B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.","volume":"7","author":"Dolcetti","year":"2007","journal-title":"Autoimmun Rev"},{"key":"R11-10-20210129","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1182\/blood-2003-05-1683","article-title":". Molecular histogenesis of post transplantation lymphoproliferative disorders.","volume":"102","author":"Capello","year":"2003","journal-title":"Blood"},{"key":"R12-10-20210129","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1600-6143.2011.03896.x","article-title":". Epidemiology of post transplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas.","volume":"12","author":"Caillard","year":"2012","journal-title":"Am J Transplant"},{"key":"R13-10-20210129","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/TP.0b013e3181b9692d","article-title":". Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma.","volume":"88","author":"Opelz","year":"2009","journal-title":"Transplantation"},{"key":"R14-10-20210129","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1600-6143.2011.03893.x","article-title":". Associations between EBV serostatus and organ transplant type in PTLD risk: an analysis of the SRTR National Registry Data in the United States.","volume":"12","author":"Dharnidharka","year":"2012","journal-title":"Am J Transplant"},{"key":"R15-10-20210129","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ajh.21911","article-title":". Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States.","volume":"86","author":"Quinlan","year":"2011","journal-title":"Am J Hematol"},{"key":"R17-10-20210129","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-2141.1992.tb06945.x","article-title":". EBV infection patterns in Hodgkins disease and normal lymphoid tissue: expression and cellular localization of EBV gene products.","volume":"82","author":"Hummel","year":"1992","journal-title":"Br J Haematol"},{"key":"R18-10-20210129","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/path.1711750303","article-title":". Epstein-Barr virus in B-cell non-Hodgkins lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types.","volume":"175","author":"Hummel","year":"1995","journal-title":"J Pathol"},{"key":"R21-10-20210129","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/TP.0b013e318199f983","article-title":". Prospective monitoring of Epstein-Barr virus DNA in adult renal transplant recipients during the early posttransplant period: role of mycophenolate mofetil.","volume":"87","author":"Holmes","year":"2009","journal-title":"Transplantation"},{"key":"R22-10-20210129","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1600-6143.2011.03478.x","article-title":". Monitoring infection with Epstein-Barr virus among seromismatch adult renal transplant recipients.","volume":"11","author":"Martin","year":"2011","journal-title":"Am J Transplant"},{"key":"R23-10-20210129","first-page":"287","article-title":". Increasing prevalence of EBV DNAemia with time from transplant in stable adult renal transplant recipients.","volume":"11","author":"Morton","year":"2011","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007890-201302150-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:48:10Z","timestamp":1618278490000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201302150-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,15]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e318276a237","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2,15]]}}}